{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:10:26Z","timestamp":1781007026112,"version":"3.54.1"},"reference-count":26,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clinical Trials"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Sample size re-estimation designs using a promising zone framework are widely used adaptive trial methodologies that guide study continuation or modification during interim analyses. Conventional implementations often base interim calculations solely on participants with available primary endpoints, overlooking predictive information from baseline and earlier visits. This underutilization can lead to inefficient interim decision-making. In this work, we adapt semi-parametric efficient estimators that leverage baseline and intermediate data for use within a promising zone sample size re-estimation design. By incorporating information from participants who have not yet reached their primary endpoint, these estimators enable more precise interim estimators while maintaining strict Type I error control through the inverse normal combination function. Using data from the ADAPT study in generalized myasthenia gravis, we illustrate how these methods integrate into a promising zone sample size re-estimation framework. Simulations based on longitudinal profiles of anti-acetylcholine receptor antibody\u2013seronegative participants demonstrate improved operating characteristics compared with the conventional approach, including increased overall power, especially for moderate effect sizes, without inflating the one-sided Type I error. Our findings highlight the practical benefit of applying existing semi-parametric estimators within promising zone sample size re-estimation designs, enabling more efficient and timely interim decision-making in settings with partially observed longitudinal data.<\/jats:p>","DOI":"10.1177\/17407745261438128","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:27:31Z","timestamp":1778318851000},"page":"248-258","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adaptive trial design and interim decision-making using incomplete longitudinal measurements: Methods and application to myasthenia gravis"],"prefix":"10.1177","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9022-913X","authenticated-orcid":false,"given":"Kush","family":"Kapur","sequence":"first","affiliation":[{"name":"argenx, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-4461","authenticated-orcid":false,"given":"Fien","family":"Gistelinck","sequence":"additional","affiliation":[{"name":"argenx, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Vandebosch","sequence":"additional","affiliation":[{"name":"argenx, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3458-3788","authenticated-orcid":false,"given":"Kelly","family":"Van Lancker","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium"},{"name":"Department of Mathematics and Data Science, Vrije Universiteit Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00159-9"},{"key":"e_1_3_2_3_2","volume-title":"Group sequential methods with applications to clinical trials","author":"Jennison C","year":"2000","unstructured":"Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. New York: Chapman & Hall, 2000."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-32562-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.01286.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2638"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.200800266"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1361"},{"issue":"1","key":"e_1_3_2_9_2","first-page":"87","article-title":"Group sequential methods for longitudinal data with stochastic treatment effect","volume":"65","author":"Spiessens B","year":"2009","unstructured":"Spiessens B, Lesaffre E, Verbeke G. Group sequential methods for longitudinal data with stochastic treatment effect. Biometrics 2009; 65(1): 87\u201395.","journal-title":"Biometrics"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2307\/2532491"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1311"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3863"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2012.01030.x"},{"key":"e_1_3_2_14_2","unstructured":"Rosenblum M Qian T Du Y et al. Adaptive enrichment designs for randomized trials with delayed endpoints using locally efficient estimators to improve precision 2015 https:\/\/people.csail.mit.edu\/mrosenblum\/papers\/adaptive_enrichment_delay.pdf"},{"key":"e_1_3_2_15_2","volume-title":"Improving power in group sequential, randomized trials by adjusting for prognostic baseline variables and short term outcomes","author":"Qian T","year":"2016","unstructured":"Qian T, Rosenblum M. Improving power in group sequential, randomized trials by adjusting for prognostic baseline variables and short term outcomes. Johns Hopkins University, Department of Biostatistics Working Papers 285, December 2016. Baltimore, MD: Johns Hopkins University."},{"issue":"4","key":"e_1_3_2_16_2","first-page":"826","article-title":"Interim analysis incorporating short-and long-term binary endpoints","volume":"61","author":"Niewczas J","year":"2019","unstructured":"Niewczas J, Kunz CU, K\u00f6nig F. Interim analysis incorporating short-and long-term binary endpoints. Biom J 2019; 61(4): 826\u2013842.","journal-title":"Biom J"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8366"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2014"},{"issue":"1","key":"e_1_3_2_19_2","article-title":"Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiency","volume":"81","author":"Van Lancker K","year":"2025","unstructured":"Van Lancker K, Betz JF, Rosenblum M. Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiency. Biometrics 2025; 81(1): ujaf020.","journal-title":"Biometrics"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2014.972509"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.2307\/2336502"},{"issue":"4","key":"e_1_3_2_22_2","first-page":"549","article-title":"The use of one and two-sided tests in drug development","volume":"8","author":"Fisher LD","year":"1998","unstructured":"Fisher LD. The use of one and two-sided tests in drug development. J Biopharm Stat 1998; 8(4): 549\u2013563.","journal-title":"J Biopharm Stat"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.00853.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4102"},{"issue":"11","key":"e_1_3_2_25_2","first-page":"1779","article-title":"An objective re-evaluation of adaptive sample size re-estimation: commentary on \u201812 years of confirmatory adaptive designs\u2019","volume":"34","author":"Mehta CR","year":"2015","unstructured":"Mehta CR, Liu L. An objective re-evaluation of adaptive sample size re-estimation: commentary on \u201812 years of confirmatory adaptive designs\u2019. Stat Med 2015; 34(11): 1779\u20131787.","journal-title":"Stat Med"},{"key":"e_1_3_2_26_2","article-title":"Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment","author":"Van Lancker K","year":"2024","unstructured":"Van Lancker K, D\u00edaz I, Vansteelandt S. Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment. arXiv preprint arXiv:240411150, 2024.","journal-title":"arXiv preprint arXiv:240411150"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06817.x"}],"container-title":["Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17407745261438128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17407745261438128","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17407745261438128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:56:21Z","timestamp":1781006181000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17407745261438128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/17407745261438128"],"URL":"https:\/\/doi.org\/10.1177\/17407745261438128","relation":{},"ISSN":["1740-7745","1740-7753"],"issn-type":[{"value":"1740-7745","type":"print"},{"value":"1740-7753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}